Loading clinical trials...
Loading clinical trials...
An Open-label, Single-arm Study to Evaluate the Tolerance and Safety of a Peptide-based Enteral Formula with Partially Hydrolyzed Guar Gum (PHGG) in the Nutritional Management of Tube-fed Children Aged 1-4 Years.
Conditions
Interventions
Enteral Formula With (PHGG)
Locations
5
United States
Children's Center for GI and Nutrition
Hollywood, Florida, United States
The University of Chicago Medicine
Chicago, Illinois, United States
Riley Children's Hospital
Indianapolis, Indiana, United States
The Children's Mercy Hospital
Kansas City, Missouri, United States
University of Utah Health Care - Huntsman Cancer Institute (HCI)
Salt Lake City, Utah, United States
Start Date
February 28, 2020
Primary Completion Date
June 1, 2021
Completion Date
June 1, 2021
Last Updated
October 15, 2024
NCT06603883
NCT06049680
NCT06905119
NCT07001943
NCT06274788
NCT06557629
Lead Sponsor
Société des Produits Nestlé (SPN)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions